IQV IQVIA Holdings Inc

$205.04

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/6/2025

About IQVIA Holdings Inc

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.

Website: https://www.iqvia.com

Sector
TRADE & SERVICES
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1478242
Address
4820 EMPEROR BLVD., DURHAM, NC, US
Valuation
Market Cap
$25.37B
P/E Ratio
19.24
PEG Ratio
0.77
Price to Book
4.18
Performance
EPS
$7.48
Dividend Yield
Profit Margin
8.91%
ROE
22.60%
Technicals
50D MA
$180.21
200D MA
$210.20
52W High
$252.88
52W Low
$135.97
Fundamentals
Shares Outstanding
176M
Target Price
$223.21
Beta
1.46

IQV EPS Estimates vs Actual

Estimated
Actual

IQV News & Sentiment

Oct 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is Veeva's Vault CRM Emerging as the Standard for Top Biopharma?
VEEV's Vault CRM is gaining traction with top biopharma firms like Merck, Gilead, and BMS, signaling its rise as the industry's commercial standard.
Sep 19, 2025 • Zacks Commentary BULLISH
Here's Why IQVIA Holdings ( IQV ) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sep 09, 2025 • Benzinga SOMEWHAT-BULLISH
This Thomson Reuters Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Charles River ( NYSE:CRL ) , Dick's Sporting Goods ( NYSE:DKS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Jefferies analyst David Windley upgraded Charles River Laboratories International, Inc.
Sep 03, 2025 • Zacks Commentary BULLISH
Here's Why IQVIA Holdings ( IQV ) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Aug 29, 2025 • Zacks Commentary NEUTRAL
Why Is DexCom ( DXCM ) Down 7% Since Last Earnings Report?
DexCom (DXCM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aug 27, 2025 • Motley Fool SOMEWHAT-BULLISH
Veeva Systems Lifts Outlook on CRM Wins
Veeva Systems ( NYSE:VEEV ) reported fiscal second quarter 2026 results on August 27, 2025, delivering $789 million in revenue and raising full-year billings guidance by $35 million. The quarter featured a strategic resolution withIQVIA ( NYSE: IQV ) , rapid Vault CRM adoption among top-20 ...
Sentiment Snapshot

Average Sentiment Score:

0.237
50 articles with scored sentiment

Overall Sentiment:

Bullish

IQV Reported Earnings

Apr 30, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper:
  • Surprise %: 0.0%
Feb 12, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $3.12
  • Estimate: $3.11
  • Whisper:
  • Surprise %: 0.4%
Oct 31, 2024
Sep 30, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $2.84
  • Estimate: $2.81
  • Whisper:
  • Surprise %: 1.1%
Jul 22, 2024
Jun 30, 2024 (Pre market)
0.07 Surprise
  • Reported EPS: $2.64
  • Estimate: $2.57
  • Whisper:
  • Surprise %: 2.7%
May 02, 2024
Mar 31, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $2.54
  • Estimate: $2.48
  • Whisper:
  • Surprise %: 2.4%
Feb 14, 2024
Dec 31, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $2.84
  • Estimate: $2.82
  • Whisper:
  • Surprise %: 0.7%
Nov 01, 2023
Sep 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $2.49
  • Estimate: $2.44
  • Whisper:
  • Surprise %: 2.0%
Aug 01, 2023
Jun 30, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $2.43
  • Estimate: $2.37
  • Whisper:
  • Surprise %: 2.5%
Apr 27, 2023
Mar 31, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $2.45
  • Estimate: $2.41
  • Whisper:
  • Surprise %: 1.7%

Financials